Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose colchicine versus naproxen for pain in acute gout
2013-001354-95Phase 4Completed
- Sponsor
- Keele University
- Start
- May 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in gout comparing Low-dose colchicine with Naproxen (2 arms). Primary endpoint: Change in worst pain intensity. Started May 2013; status: completed.
02
Drugs
colchicinenaproxen
03
Conditions
gout
Beyond the preview
Go deeper on 2013-001354-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001354-95.